How Biotech ETFs Have Performed During the Valeant Stock Crash

Home › How Biotech ETFs Have Performed During the Valeant Stock Crash

Biotech ETFs have been the focus of many investors this week after Valeant Pharmaceuticals Intl. Inc. shares dropped more than 46% last week.

05.11	Boeing strike ends as workers back 38% pay rise deal
05.11	Tropical Storm Rafael Public Advisory Number 6A
05.11	Summary for Tropical Storm Rafael (AT3/AL182024)
05.11	Tropical Storm Rafael Graphics
05.11	Atlantic Tropical Weather Outlook
05.11	Eastern North Pacific Tropical Weather Outlook
05.11	Tropical Storm Rafael Graphics
05.11	Tropical Storm Rafael Forecast Discussion Number 6
More »

je.st